Back
Stoke Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
67
STOK
Stoke Therapeutics
Last Price:
13.51
Seasonality Move:
3.05%
Sell
14
NBY
NovaBay Pharmaceuticals
Last Price:
0.10
Seasonality Move:
3.92%
Buy
67
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy, Sell or Hold?
- The current Stoke Therapeutics [STOK] share price is $13.50. The Score for STOK is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.10. The Score for NBY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $13.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
STOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.27 | Buy |
Relative Strength Index (14 RSI): | 79.11 | Buy |
Chaikin Money Flow: | 1219535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.48 - 9.66) | Buy |
Bollinger Bands (100): | (3.83 - 7.13) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 29.75 | Sell |
Chaikin Money Flow: | -834219 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.13 - 0.15) | Sell |
Bollinger Bands (100): | (0.14 - 0.28) | Sell |
STOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.56 | Buy |
20-day SMA: | 7.65 | Buy |
50-day SMA: | 6.23 | Buy |
200-day SMA: | 6.04 | Buy |
8-day EMA: | 9.81 | Buy |
20-day EMA: | 8.06 | Buy |
50-day EMA: | 6.75 | Buy |
200-day EMA: | 6.57 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.13 | Sell |
20-day SMA: | 0.14 | Sell |
50-day SMA: | 0.15 | Sell |
200-day SMA: | 0.4 | Sell |
8-day EMA: | 0.13 | Sell |
20-day EMA: | 0.14 | Sell |
50-day EMA: | 0.16 | Sell |
200-day EMA: | 0.67 | Sell |
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.27 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and an increase next year of $0.74 per share.
Stoke Therapeutics Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |